Diabetes News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 17 articles
FDA expands Tzield to certain pediatric patients with recent Stage 3 T1D
FDA · diabetes · 5 min
Dr. Sarah MitchellFDA Clears First OTC CGM for Children: Dexcom Expands Stelo
FDA · diabetes · 4 min
Dr. Sarah MitchellChile warning labels on food: new evidence on efficacy and obesity risk
diabetes · 5 min
Dr. Sarah MitchellGLP-1 usage statistics show broad uptake and mixed clinical signals
GLP-1 · 5 min
Dr. Sarah MitchellMariTide Phase 2 obesity data show up to 20% weight loss at one year
obesity · 5 min
Dr. Sarah MitchellMariTide Phase 2: Amgen reports up to 20% weight loss at one year
obesity · 5 min
Dr. Sarah MitchellFDA Approves LANGLARA Interchangeable Biosimilar to Lantus Insulin - Lannett Company Enters Diabetes Market
FDA · Diabetes/Endocrinology · 4 min
Dr. Emily CarterNovo Nordisk's Oral Ozempic Becomes First FDA-Approved Pill GLP-1 for Type 2 Diabetes with Cardiovascular Protection
FDA · Type 2 diabetes with cardiovascular risk reduction · 3 min
James Chen, PharmDGLP-1 Eating Disorder Risk: What You Need to Know
FDA · Obesity and type 2 diabetes · 4 min
Dr. Hannah O'ConnorAscletis Completes Enrollment for ASC30 Oral GLP-1 Diabetes Drug Phase II Trial
3 min
Dr. Natalie HughesAscletis Completes Enrollment in Phase II Trial of ASC30 Oral GLP-1 Diabetes Drug
2 min
Dr. Natalie HughesNovo Nordisk's Oral Semaglutide Shows Promise as First GLP-1 Therapy for Children with Type 2 Diabetes
Type 2 Diabetes · 4 min
Dr. Emily CarterExplore intelligence